Literature DB >> 19652951

Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients.

Anselmo Caricato1, Luca Montini, Giuseppe Bello, Vincenzo Michetti, Riccardo Maviglia, Maria G Bocci, Giovanna Mercurio, Salvatore M Maggiore, Massimo Antonelli.   

Abstract

OBJECTIVE: To investigate incidence, risk factors and outcome of Acinetobacter baumanii infection in trauma patients. DESIGN AND
SETTING: A retrospective analysis of prospectively collected data of all trauma patients admitted to a general intensive care unit (ICU) of a 1,500-bed university hospital over 3 years. PATIENTS: Three hundred thirty trauma patients were included in the study.
RESULTS: Thirty-six (10.9%) cases of A. baumanii infection were observed; 29 of them were late onset pneumonia. Patients with A. baumanii infection had a significantly higher Injury Severity Score (ISS) (p = 0.02), a lower Glasgow Coma Scale (GCS) on ICU admission (p = 0.03), stayed longer in the ICU (p = 0.00001), were mechanically ventilated for a longer period of time (p = 0.00001), were more frequently admitted to the emergency department with hypotension (p = 0.02), and had trans-skeletal traction for more than 3 days (p = 0.003) in comparison to the 294 patients who did not develop A. baumanii infection. At multivariate analysis the time spent on mechanical ventilation (p = 0.02) and the presence of long-term trans-skeletal traction (p = 0.04) were the only independent risk factors for A. baumanii infection. Patients with A. baumanii infection had a high mortality rate (9 out of 36; 25.0%). ISS (p = 0.003), GCS (p = 0.001) and older age (p = 0.00001), but not A. baumanii infection (p = 0.15), were independently correlated with mortality.
CONCLUSIONS: In trauma patients prolonged mechanical ventilation and delayed fracture fixation with the persistence of trans-skeletal traction were major risk factors for A. baumanii infection. The presence of this infection was not correlated with mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19652951     DOI: 10.1007/s00134-009-1582-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  30 in total

1.  The bacterial flora of battle wounds at the time of primary debridement; a study of the Korean battle casualty.

Authors:  R B LINDBERG; T F WETZLER; J D MARSHALL; A NEWTON; J G STRAWITZ; J M HOWARD
Journal:  Ann Surg       Date:  1955-03       Impact factor: 12.969

2.  Impact of ventilator-associated pneumonia in patients with severe head injury.

Authors:  M Dolores Rincón-Ferrari; Juan M Flores-Cordero; S Ramón Leal-Noval; Francisco Murillo-Cabezas; Aurelio Cayuelas; M Angeles Muñoz-Sánchez; J Ignacio Sánchez-Olmedo
Journal:  J Trauma       Date:  2004-12

Review 3.  Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1996-05       Impact factor: 21.405

4.  Early versus delayed stabilization of femoral fractures. A prospective randomized study.

Authors:  L B Bone; K D Johnson; J Weigelt; R Scheinberg
Journal:  J Bone Joint Surg Am       Date:  1989-03       Impact factor: 5.284

5.  Predictors of mortality in Acinetobacter baumannii bacteremia.

Authors:  Hsin Pai Chen; Te Li Chen; Chung Hsu Lai; Chang Phone Fung; Wing Wai Wong; Kwok Woon Yu; Cheng Yi Liu
Journal:  J Microbiol Immunol Infect       Date:  2005-04       Impact factor: 4.399

6.  Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility.

Authors:  H Wisplinghoff; M B Edmond; M A Pfaller; R N Jones; R P Wenzel; H Seifert
Journal:  Clin Infect Dis       Date:  2000-10-04       Impact factor: 9.079

7.  Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.

Authors:  C M Luna; P Vujacich; M S Niederman; C Vay; C Gherardi; J Matera; E C Jolly
Journal:  Chest       Date:  1997-03       Impact factor: 9.410

8.  Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Authors:  Rebecca H Sunenshine; Marc-Oliver Wright; Lisa L Maragakis; Anthony D Harris; Xiaoyan Song; Joan Hebden; Sara E Cosgrove; Ashley Anderson; Jennifer Carnell; Daniel B Jernigan; David G Kleinbaum; Trish M Perl; Harold C Standiford; Arjun Srinivasan
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  Long bone fractures in the polytrauma patient. The role of early operative fixation.

Authors:  S B Beckman; D J Scholten; B W Bonnell; C D Bukrey
Journal:  Am Surg       Date:  1989-06       Impact factor: 0.688

10.  Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent.

Authors:  J Rello; M Rué; P Jubert; G Muses; R Soñora; J Vallés; M S Niederman
Journal:  Crit Care Med       Date:  1997-11       Impact factor: 7.598

View more
  10 in total

1.  Trauma is associated with a better prognosis in intensive care patients with Acinetobacter infections.

Authors:  A C Tonacio; M S Oliveira; L M S Malbouisson; A S Levin
Journal:  Infection       Date:  2013-10-30       Impact factor: 3.553

2.  Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii.

Authors:  Leticia V Bentancor; Ana Camacho-Peiro; Cagla Bozkurt-Guzel; Gerald B Pier; Tomás Maira-Litrán
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

3.  Prediction of the Risk of Hospital Deaths in Patients with Hospital-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii Infection: A Multi-Center Study.

Authors:  Hongmei Shu; Lijuan Li; Yimin Wang; Yiqun Guo; Chunlei Wang; Chunxia Yang; Li Gu; Bin Cao
Journal:  Infect Drug Resist       Date:  2020-11-19       Impact factor: 4.003

4.  Prognostic Value of Sequential Organ Failure Assessment (SOFA) Score in Critically-Ill Combat-Injured Patients.

Authors:  Shannon L McCarthy; Laveta Stewart; Faraz Shaikh; Clinton K Murray; David R Tribble; Dana M Blyth
Journal:  J Intensive Care Med       Date:  2022-02-16       Impact factor: 2.889

Review 5.  Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-01-08       Impact factor: 17.440

6.  Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.

Authors:  Guanpingshen Luo; Lin Lin; Ashraf S Ibrahim; Beverlie Baquir; Paul Pantapalangkoor; Robert A Bonomo; Yohei Doi; Mark D Adams; Thomas A Russo; Brad Spellberg
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

7.  Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care.

Authors:  Jennifer Townsend; An Na Park; Rita Gander; Kathleen Orr; Doramarie Arocha; Song Zhang; David E Greenberg
Journal:  Open Forum Infect Dis       Date:  2015-03-12       Impact factor: 3.835

8.  Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms.

Authors:  Marianna Di Bonito; Simona Caiazzo; Marta Iannazzone; Viviana Miccichè; Giuseppe De Marco; Edoardo De Robertis; Rosalba Tufano; Ornella Piazza
Journal:  Transl Med UniSa       Date:  2012-04-30

9.  Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit.

Authors:  Kaweesak Chittawatanarat; Wuttipong Jaipakdee; Narain Chotirosniramit; Kamtone Chandacham; Tidarat Jirapongcharoenlap
Journal:  Infect Drug Resist       Date:  2014-08-16       Impact factor: 4.003

10.  Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria.

Authors:  Eman G Youssef; Lina Zhang; Sondus Alkhazraji; Teclegiorgis Gebremariam; Shakti Singh; Nannette Y Yount; Michael R Yeaman; Priya Uppuluri; Ashraf S Ibrahim
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.